Estrella Immunopharma (ESLA) Treasury Shares (2021 - 2026)
Estrella Immunopharma (ESLA) posted quarterly Treasury Shares of $598379.0 for Q1 2026, up 1931.02% year-over-year from $29462.0 in Q1 2025, and little changed quarter-over-quarter from $598379.0 in Q4 2025.
Estrella Immunopharma (ESLA) Treasury Shares (2021 - 2026) Analysis & Trends
Estrella Immunopharma (ESLA) has reported Treasury Shares for 3 consecutive years, with $598379.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Treasury Shares rose 1931.02% year-over-year to $598379.0; the TTM figure through Mar 2026 stood at $598379.0 (up 1931.02% YoY), while the FY2025 annual figure was $598379.0, up 5.18% from the prior year.
- Treasury Shares held at $598379.0 in Q1 2026 per ESLA's latest filing, from $598379.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $10.2 million in Q1 2026 and bottomed at $74890.0 in Q1 2024.
- Historically, Treasury Shares has averaged $2.2 million across 5 years, with a median of $712750.5 in 2022.
- Annual changes were most pronounced in 2025 — Treasury Shares slumped 64.96% — and 2026, when it soared 1931.02%.
- Estrella Immunopharma's Treasury Shares stood at $568917.0 in 2024, then grew by 5.18% to $598379.0 in 2025, then changed by 0.0% to $598379.0 in 2026.
- Business Quant data shows ESLA's Treasury Shares at $598379.0 in Q1 2026, $598379.0 in Q4 2025, and $598379.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Estrella Immunopharma | 32.29 Mn | 32.14 Mn | - | 515,281.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.81 Mn |
| Jun 30, 2026 | 9.81 Mn |
| Jun 30, 2026 | 598,379.00 |
| Jun 30, 2026 | 598,379.00 |
| Mar 31, 2026 | 10.18 Mn |
| Mar 31, 2026 | 598,379.00 |
| Mar 31, 2026 | 598,379.00 |
| Mar 31, 2026 | 10.18 Mn |
| Dec 31, 2025 | 598,379.00 |
| Dec 31, 2025 | 515,281.00 |
| Dec 31, 2025 | 515,281.00 |
| Dec 31, 2025 | 598,379.00 |
| Sep 30, 2025 | 515,281.00 |
| Sep 30, 2025 | 515,281.00 |
| Sep 30, 2025 | 598,379.00 |
| Sep 30, 2025 | 598,379.00 |
| Jun 30, 2025 | 515,281.00 |
| Jun 30, 2025 | 598,379.00 |
| Jun 30, 2025 | 598,379.00 |
| Jun 30, 2025 | 515,281.00 |